GLAXO SMITH KLINE

Eltrombopag-revolade

"Eltrombopag" is the Drug / Molecule content in “Revolade”. Eltrombopag is a medication that has been developed for certain conditions that lead to thrombocytopenia. It is a small molecule agonist of the c-mpl receptor, which is the physiological target of the hormone thrombopoietin.

Details
Specification

Indication

Revolade helps to increase the number of platelets, a type of blood cell that helps to reduce or prevent bleeding. The use of Revolade is to increase and maintain the platelet count prior to and throughout antiviral treatment of Hepatitis C virus infection

Note

Precaution

Revolade is a prescription drug and should be used under proper medical guidance and advice.
Revolade may damage your liver and cause serious, even life threatening, illness.You must have blood tests to check your liver before you start taking Revolade and during treatment.
Use a contraceptive to prevent pregnancy during treatment with Revolade..

Updated On Oct 25, 2019 by Admin